A Review of Maximizing Muscle Building Capabilities with Anabolic Enzymes

Elvis Agbons, Ohis Egbaidomeh


Building muscle at a rate faster than the human body would under normal circumstances is of great importance in skills and activities that require intense muscular effort. Although physical training stands as the backbone of muscle building, physiological variations make it an unfair yardstick in measuring individual efforts. Other methods of muscle building such as specialised nutrition and the use of digestive enzymes in breaking down proteins for quick absorption are also commonly used together with physical training. The use of anabolic substances, however, has proved more successful than any of the aforementioned methods. Nevertheless, with it comes ethical, legal, and clinical issues especially in sports. In spite of this, athletes still find ways of circumventing test protocols which have been a major issue for the World Anti-Doping Agency. However, advancements in science have opened the doorway for anabolic enzymes which are the ultimate muscle growers to be more or less, directly manipulated. One method is gene doping which involves altering gene expressions. The future of muscle building lies in man’s ability to decisively alter the functioning of these enzymes directly.


Muscle building, anabolic enzymes, mTOR, myostatin

Full Text:



Antonio, J. 1. & Gonyea, W. J. (1993). Skeletal muscle fiber hyperplasia. Medical Science & Sports Exercise, 25(12), 1333-1345.

Barry, P. (2008). Finding the golden genes. Science News, 174(3), 16-21.

Birzniece, V. (2015). Doping in sport: effects, harm and misconceptions. International Medicine Journal, 45(3), 239-48.

Bond, P. (2016). Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance. Journal of International Society for Sports Nutrition, 13(8).

Campbell, N. A., Reece, J. B., Urry, L. A., Cain, M. L., Wasserman, S. A., Minorsky, P. V., & Jackson, R. B. (2005). Biology (8th Ed.). Pearson Benjamin Cummings, International Edition.

Chambers, A. M. S. & Kravitz, L. (2016). Nutrient Timing: The New Frontier in Fitness Performance. https://www.unm.edu/~lkravitz/Article%20folder/nutrientUNM.html.

Drummond, Dreyer, Fry, Glynn, & Rasmussen (2009). Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signalling. Journal of Applied Physiology, 106, 1374–1384.

Dubois, S. (2016).What Digests First, Protein, Carbohydrates or Fat? Healthy Eating. Demand Media.

Egerman, M. A. & Glass, D. J. (2014). Signalling pathways controlling skeletal muscle mass. Critical Review of Biochemistry & Molecular Biology, 49(1), 59–68.

Elkina, Y., Haehling, S., Anker, S. D., & Springer, J. (2011). The role of myostatin in muscle wasting: an overview. Journal of Cachexia, Sarcopenia & Muscle, 2(3), 143–151.

Fahey, T. D. (1998). Anabolic-Androgenic Steroids: Mechanism of Action and Effects on Performance. Encyclopedia of Sports Medicine and Science. Chico, CA: Internet Society for Sport Science http://sportsci.org.

Hay, N. & Sonenberg, N. (2004). Upstream and downstream of mTOR. Genes & Development, 18(16), 1926–45.

Health Warburton, D. E. R., Nicol, C. W., & Bredin, S. S. D. (2006). Benefits of physical activity: the evidence. Canadian Medical Association Journal, 174(6), 801–809.

Hill, J. J., Qiu, Y., Hewick, R. M., & Wolfman, N. M. (2008). Regulation of Myostatin in Vivo by Growth and Differentiation Factor-Associated Serum Protein-1: A Novel Protein with Protease Inhibitor and Follistatin Domains. Molecular Endocrinology, 17(6).

Ivy, J. & Portman, R. (2004). Nutrient timing: The future of sports nutrition. California, Basic Health Publications Inc.

Jesse, R. (2013). Bodybuilders Through the Ages. Jump up.

Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013). mTOR is a key modulator of ageing and age-related disease. Nature, 493(7432), 338–45.

Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502–521.

Kwon, Y. M. S. & Kravitz, L. (2016). How do muscles grow? Retrieved from unm.edu.

Laplante, M. & Sabatini, D. M. (2009). mTOR signalling at a glance. Journal of Cell Science, 122, 3589-3594.

McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003). Myostatin negatively regulates satellite cell activation and self-renewal. Journal of Cell Biology, 162(6), 1135–1147.

Mero, A. & Hulmi, J. (2016). Regulatory mechanisms of muscle growth and training. Nutrition and physical activity. Dopinglinkki.com. A-Clinic Foundation.

Millard-Stafford, M., Childers, W. L., Conger, S. A., Kampfer, A. J., & Rahnert, J. A. (2008). Recovery nutrition: timing and composition after endurance exercise. Current Sports Medicine Report, 7(4), 193-201.

Mitra, A., Luna, J. I., Marusina, A. I., Merleev, A., Kundu-Raychaudhuri, S., Fiorentino, D., Raychaudhuri, S. P., & Maverakis, E. (2015). Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma. The Journal of Investigative Dermatology, 135(11), 2873–2876.

Momaya, A., Fawal, M., & Estes, R. (2015). Performance-enhancing substances in sports: a review of the literature. Sports Medicine, 45(4), 517–531.

Nader, G. A. (2005). Molecular determinants of skeletal muscle mass: getting the “AKT” together. The International Journal of Biochemistry & Cell Biology, 37(10), 1985–1996.

Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009). DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell, 137, 873-886.

Philip, B., Lu, Z., & Gao, Y. (2005). Regulation of GDF-8 signalling by the p38 MAPK. Cell Signal, 17, 365–75.

Phillips, S. M. (2014). A brief review of critical processes in exercise-induced muscular hypertrophy. Sports Medicine, 44(1), 71–77.

Proud, (2007). Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochemical Journal, 403, 217–234.

Rasmussen, R. B. & Phillips, S. M. (2003). Contractile and Nutritional Regulation of Human Muscle Growth. Exercise and Sport Science Reviews, 31(3), 127-131.

Reynolds, G. (2007, June). Outlaw DNA. The New York Times.

Schiaffino, S. & Mammucari C. (2011). Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skeletal Muscle, 1(4).

Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013). Mechanisms regulating skeletal muscle growth and atrophy. The FEBS Journal, 280(17).

Schwarzenegger, A. (1999). The New Encyclopedia of Modern Bodybuilding. Fireside, NY.

Shannon C. (2009). Anabolic Enzymes: Maximizing Your Muscle-Building Potential! www.bodybuilding.com. Retrieved September, 2016.

Smith, J. (2016). Energy Usage During Exercise: How It Affects Your Workouts. Precor Inc.

Supasyndh, O., Satirapoj, B., Aramwit, P., Viroonudomphol, D., Chaiprasert, A., Thanachatwej, V., Vanichakarn, S., & Kopple, J. D. (2012). Effect of Oral Anabolic Steroid on Muscle Strength and Muscle Growth in Hemodialysis Patients. Clinical Journal of the American Society of Nephrology, 8(2), 271-279.

Tang, J. E. & Phillips, S. M. (2009). Maximizing muscle protein anabolism: the role of protein quality. Protein, amino acid metabolism and therapy. In E. Roth & E. Volpi (Eds.). Current Opinion in Clinical Nutrition & Metabolic Care, 12(1), 66–71.

Tsuchida, K. (2008). Targeting myostatin for therapies against muscle-wasting disorders. Current Opinion in Drug Discovery & Development, 11(4), 487–494.

U.S. Department of Health and Human Services, (June 2006). Your Guide to Physical Activity and Your Heart. National Institutes of Health, National Heart, Lung, and Blood Institute.

Van der Gronde, T., de Hon, O., Haisma, H. J., & Pieters, T. (2013). Gene doping: an overview and current implications for athletes. British Journal of Sports Medicine, 47(11), 670-8. Review.

Wang, X. & Proud, C. G. (2006). The mTOR Pathway in the Control of Protein Synthesis. Physiology, 21(5), 362-369.

World Anti-Doping Agency. (2016). Gene Doping. Page archived January 7, 2016.

Wullschleger, S., Loewith, R., & Hall, M. N. (2006). TOR signalling in growth and metabolism. Cell, 124(3), 471–84.

DOI: http://dx.doi.org/10.15282/mohe.v6i2.147

Movement, Health & Exercise (MoHE) Journal

Innovative Manufacturing, Mechatronics & Sports Lab (iMAMS)
Faculty of Manufacturing Engineering
Universiti Malaysia Pahang
26600 Pekan

Tel.: +609 424 6358

Email: admin@mohejournal.com

DOI: http://dx.doi.org/10.15282/mohe